Clinical Indication

Behcet’s disease


Alternative to infliximab once established on therapy.
Subcutaneous  preparation able to be administered at home.

Date of classification

September 2015


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.